Inflammatory cytokines and cell response in surgery

Surgery

Volumn 127, Issue 2, 2000, Pages 117-126

  Lin, Edward ^a,b   Calvano, Steve E ^a,b   Lowry, Stephen F ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CYTOKINE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL FUNCTION; HORMONAL REGULATION; HUMAN; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; REVIEW; SURGICAL INFECTION; SURGICAL INJURY;

EID: 0033962077     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.101584     Document Type: Article

References (73)

1. 1. Spink J, Cohen J, Synergy and specificity in induction of gene activity by proinflammatory cytokines: potential therapeutic targets. Shock 1997;7:405-12.
2. 2. Guirao X, Lowry SF. Biologic control of injury and inflammation: Much more than too little or too late. World J Surg 1996;20:437-46.
3. 3. Lin E, Lowry SF. The human response to endotoxin. Sepsis 1998; 2:255-62.
4. 4. Van Berge Henegouwen MI, van der Poll T, van Deventer SJH, Gouma DJ. Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. Am J Surg 1998;175:311-16.
5. 5. Lin E, Calvano SE, Lowry SF. Cytokine response in abdominal surgery. In: Schein M, Wise L, editors. Cytokines and the abdominal surgeon. Austin: Landes Bioscience; 1998:17-34.
6. 6. Enayati P, Brennan MF, Fong Y. Systemic and liver cytokine activation. Arch Surg 1994;124:1159-64.
7. 7. Van der Poll, Lowry SF. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 1995; 3:1-12.
8. 8. Van der Poll, Lowry SF. Endogenous mechanisms regulating TNF and IL-1 during sepsis. In: Vincent JL, editor. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag; 1995:385-97.
9. 9. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
10. 10. Fong Y, Lowry SF. Cytokines and the cellular response to injury and infection. In: Wilmore DW, Cheung LY, Harken AH, Holcroft JW, Meakins JL, editors. Surgery. New York: Scientific American 1996;15: p 1-21.
11. 11. Schafer M, Carter L, Stein C. Interleukin-1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in immune tissue. Proc Natl Acad Sci USA 1994;91:4219-23.
12. 12. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxic shock. Nature 1990;348:550-52.
13. 13. Abraham E., Regan RF. The effects of hemorrhage and trauma on interleukin-2 production. Arch Surg 1983; 120:1341-46.
14. 14. Oka M, Hirazawa K, Yamamoto K, et al. Induction of Fasmediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg 1996;223:434-40.
15. 15. Keegan AD, Ryan J J, Paul WE. IL-4 regulates growth and differentiation by distinct mechanisms. The Immunologist 1996;4:194-8.
16. 16. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinfiammatory cytokines. J Immunol 1991;147:3408-12.
17. 17. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al. IL-6 is an antiinfiammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-20.
18. 18. Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 delays neutrophil apoptosis. Arch Surg 1996; 131:24-30.
19. 19. Tilg H, Trehu E, Atkins MB. Interleukin-6 (IL-6) as an antiinfiammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83:113-8.
20. 20. Patrick DA, Moore FA, Moore EE, et al. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 1996;172:425-31.
21. 21. Van Zee KJ, Fischer F., Hawes AS, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992;148:1746-52.
22. 22. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.
23. 23. Marshall JD, Aste-Amezaga M, Chehimi SS, Murphy M, Olsen H, Trinchieri G. Regulation of human IL-18 mRNA expression. Clin Immunol 1999;90:15-21.
24. 24. Van der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995;155:5397-401.
25. 25. Steibhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL. Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 1999;162:5437-43.
26. 26. Lauw FN, Dekkers PE, te Velde AA, Speelman P, Levi M, Kurimoto M, et al. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis 1999;179:646-52.
27. 27. Carson WE, Yu H, Dierksheide J, Pfeifer K, Bouchard P, Clark R, et al. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 1999;162:4943-51.
28. 28. Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998;17:1-52.
29. 29. Manna SK, Aggarwal BB. Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase: comparison with interleukin-13. J Biol Chem 1998;273:33333-41.
30. 30. Etter H, Althaus R, Eugster HP, Santamaria-Babi LF, Weber L, Moser R. IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression. Cytokine 1998;10:395-403.
31. 31. Alleva DG, Kaser SB, Monroy MA, Fenton MJ, Belier DI. IL-15 functions as a potent autocrine regulator of macrophage proinfiammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 1997;159:2941-51.
32. 32. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Ruckert R, et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997;3:1124-8.
33. 33. McDonald PP, Russo MP, Ferrini S, Cassatella MA. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils. Blood 1998; 92:4828-35.
34. 34. Musso T, Calosso L, Zucca M, Millesimo M, Puliti M, Bulfone-Paus S, et al. Interleukin-15 activates proinfiammatory and antimicrobial functions in polymorphonuclear cells. Infect Immun 1998;60:2640-7.
35. 35. Puren AJ, Fantuzzi G, Dinarello CA. Gene expression, synthesis, and secretion of interleukin-18 and interleukin-1β are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci USA 1999;96:2256-61.
36. 36. Bohn E, Sing A, Zumbihl R, Bielfeldt C, Okamura H, Kurinoto M, et al. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 1998; 160:299-307.
37. 37. Hoshino K, Tsutsui H, Kawai T, Takeda K, Nakanishi K, Takeda Y, et al. Generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol 1999;162:5041-4.
38. 38. Kohka H, Yoshino T, Iwagaki H, Sakuma I, Tanimoto T, Matsuo Y, et al. Interleukin-18/interferon-γ-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 1998; 64:519-27.
39. 39. Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, et al. IL-18 accounts for both TNF-α-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997;159:3961-7.
40. 40. Oberholzer A, Steckholzer U, Okamura H, Kurimoto M, Trentz O, Ertel W. Increased circulating levels of interleukin-18 during severe sepsis in humans. Surg Forum 1998;49:88-90.
41. 41. Heinzel FP, Rerko DM, Ling P, et al. Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immunol 1994;62:4244-9.
42. 42. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
43. 43. Barbul A, Regan MB. The regulatory role of T lymphocytes in wound healing. J Trauma 1990;30:S97-S102.
44. 44. Keel M, Ungethum U, Steckholzer U, Niederer E, Hartung T, Trentz O, et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997;90:3356-63.
45. 45. Ertel W, Keel M, Infanger M, Ungethum U, Steckholzer U, Trentz O. Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through upregulation of protein-tyrosine phosphorylation. J Trauma 1998;44:767-75.
46. 46. Fanning NF, Kell MR, Shorten GD, Kirwan WO, Bouchier-Hayes D, Cotter TG, et al. Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock 1999;11:167-74.
47. 47. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type-1/type-2 T helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996;119:316-25.
48. th ed. New York: McGraw-Hill;1999:3-51.
49. 49. Zedler S, Bone RC, Baue AE, Donnersmarck GH, Faist E. T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 1999;27:66-72.
50. 50. Berguer R, Bravo N, Bowyer M, Egan C, Knolmayer T, Ferrick D. Major surgery suppresses maximal production of helper T-cell type 1 cytokines without potentiating the release of helper T-cell type 2 cytokines. Arch Surg 1999;134:5404.
51. 51. Lin E, Calvano SE, Lowry SF. Disordered apoptosis as a mechanism for adverse outcome in critical illness. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag;1997:91-9.
52. 52. Lin E, Calvano SE, Lowry SF. The biologic control of systemic inflammatory response. Curr Opin Crit Care 1997;3:299-307.
53. 53. Ksontini R, MacKay SLD, Moldawer LL. Revisiting the role of tumor necrosis factor α and the response to surgical injury and inflammation. Arch Surg 1998;133:558-67.
54. 54. Van Zee KJ, Stackpole SA, Montegut WJ, et al. A human tumor necrosis factor (TNF) α mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon. J Exp Med 1994;179:1185-91.
55. 55. Welborn MB, van Zee K, Edwards PD, et al. A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med 1996;184:165-71.
56. 56. Weiss T, Grell M, Hessabi S, et al. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80. J Immunol 1998;158:2398-404.
57. 57. Lin ZG, Hsu HL, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 1996;87:565-76.
58. 58. Anrather J, Csizmadia V, Brostjan C, Soares JP, Bach FH, Winkler H. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB. J Clin Invest 1997;99:763-72.
59. 59. Bohrer H, Qin F, Zimmermann T, et al. The role of NF-κB in the mortality of sepsis. J Clin Invest 1997;100:972-85.
60. 60. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-α-induced apoptosis. Genes Dev 1999;13:382-7.
61. 61. Moulding DA, Quayle JA, Hart CA, Edwards SW. Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood 1998;92:2495-502.
62. 62. Wissink S, van Heerde EC, van der Burg B, van der Saag PT. A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol Endocrinol 1998;12:355-63.
63. 63. Brostjan C, Anrather J, Csizmadia V, Natarajan G, Winkler H. Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-Jun. J Immunol 1997;158:3836-44.
64. 64. Ayala A, Herdon CD, Lehman DL, DeMaso CM, Ayala CA, Chaudry IH. The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor. Shock 1995;3:259-67.
65. 65. Zubiaga AM, Munoz E, Huber BT. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol 1992;149:107-12.
66. 66. Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181-8.
67. 67. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993;150:1999-2006.
68. 68. Van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. J Clin Endocrinol Metab 1996;3604-6.
69. 69. Kawamura T, Inada K, Nara N, Wakusawa R, Endo S. Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 1999;27:545-8.
70. 70. Van der Poll T, Lowry SF. Epinephrine inhibits endotoxin-induced IL-1β production: roles of tumor necrosis factor-α and IL-10. Am J Physiol 1997;273:R1885-90.
71. 71. Van der Poll T, Lowry SF. Lipopolysaccharide-induced interleukin-8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect immun 1997;65:2378-81.
72. 72. Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin-10 production during human endoloxemia. J Clin Invest 1996;97:713-9.
73. 73. Lin E, Calvano SE, Lowry SF. Tumor necrosis factor receptors in systemic inflammation. In: Vincent JL, ed. Update in Intensive Care and Emergency Medicine: Immune Response in Critical Illness. Berlin: Springer-Verlag; 1999 (in press)